Experimental infection and protection against ... - TI Pharma

NF135.C10: a new Plasmodium falciparum clone for controlled human malaria
infections
28. Epstein JE, Rao S, Williams F, et al. Safety and clinical outcome of experimental
challenge of human volunteers with Plasmodium falciparum-infected
mosquitoes: an update. J Infect Dis 2007; 196:145-54.
29. Edelman R, Hoffman SL, Davis JR, et al. Long-term persistence of sterile
immunity in a volunteer immunized with X-irradiated Plasmodium falciparum
sporozoites. J Infect Dis 1993; 168:1066-70.
30. Kester KE, McKinney DA, Tornieporth N, et al. Efficacy of recombinant
circumsporozoite protein vaccine regimens against experimental Plasmodium
falciparum malaria. J Infect Dis 2001; 183:640-7.
31. Rickman LS, Jones TR, Long GW, et al. Plasmodium falciparum-infected
Anopheles stephensi inconsistently transmit malaria to humans. Am J Trop Med
Hyg 1990; 43:441-5.
32. Frischknecht F, Baldacci P, Martin B, et al. Imaging movement of malaria
parasites during transmission by Anopheles mosquitoes. Cell Microbiol 2004;
6:687-94.
33. Rosenberg R, Wirtz RA, Schneider I, Burge R. An estimation of the number of
malaria sporozoites ejected by a feeding mosquito. Trans R Soc Trop Med Hyg
1990; 84:209-12.
34. Ponnudurai T, Lensen AH, van Gemert GJ, Bolmer MG, Meuwissen JH. Feeding
behaviour and sporozoite ejection by infected Anopheles stephensi. Trans R Soc
Trop Med Hyg 1991; 85:175-80.
35. Roestenberg M, McCall M, Hopman J, et al. Protection against a malaria
challenge by sporozoite inoculation. N Engl J Med 2009; 361:468-77.
36. McCall MB, Roestenberg M, Ploemen I, et al. Memory-like IFN-gamma response
by NK cells following malaria infection reveals the crucial role of T cells in NK
cell activation by P. falciparum. Eur J Immunol 2010; 40:3472-7.
37. Teirlinck AC, McCall MB, Roestenberg M, et al. Longevity and Composition of
Cellular Immune Responses Following Experimental Plasmodium falciparum
Malaria Infection in Humans. PLoS Pathog 2011; 7:e1002389.
38. Good MF, Stanisic D, Xu H, Elliott S, Wykes M. The immunological challenge to
developing a vaccine to the blood stages of malaria parasites. Immunol Rev
2004; 201:254-67.
39. Yang C, Shi YP, Udhayakumar V, et al. Sequence variations in the non-repetitive
regions of the liver stage-specific antigen-1 (LSA-1) of Plasmodium falciparum
from field isolates. Mol Biochem Parasitol 1995; 71:291-4.
40. Borrmann S, Matuschewski K. Protective immunity against malaria by 'natural
immunization': a question of dose, parasite diversity, or both? Curr Opin
Immunol 2011; 23:500-8.
149